News and Announcements
Tesserent Limited (ASX:TNT) Secures $1m Contract and Launches Two New Services
- Published July 11, 2017 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
Tesserent is a specialist in managed cyber security. The company has announced to shareholder an update on key business matters following the closure of the FY2017.
KEY TAKEAWAYS:
- Tesserent was cash flow positive in the June quarter.
- The company secured $1.03M total contract value in new business during the quarter of June. The revenue made will be realised over the next 3 years.
- During March, Tesserent began a restructure of the sales team. This process is still on-going, however changes within the business have already resulted positively on sales activity and revenue.
- Tesserent, secure $530K TCV of new SIEM contracts during the quarter of June.
- Tesserent was delighted to have been selected by the Australian Cyber Security Growth Network (ACSGN) to provide a managed SIEM service.
- Tesserent continues to grow with product offerings, launching two new proprietary products during the June Quarter.
- ‘CyberBIZ’ is a comprehensive SMB focused managed service offering.
- ‘Portal Defence’ is a program which offers highly secure interface for web portal.
Tesserent CEO, Keith Glennan said:
“We are pleased to have finished the financial year with strong sales results, an expanding set of notable customers, and a continued focus on product development. Tesserent is not only continuing to provide world-class managed services to new and existing customers; we are leading the industry with innovative product development, cleverly defined to meet the emerging needs of the market.”
“We’ve all worked extremely hard to deliver this result during the June quarter, however importantly, we’ve also established a solid pipeline for the quarter ahead. We are focused on building upon this momentum and delivering further growth in the new financial year.”
Company Updates
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
The Light Fantastic: Why Invion’s Photodynamic Therapy May Be Attracting Big Pharma’s Attention
Invion Limited is challenging the status quo in oncology with its Photosoft™ platform, a precision therapy that uses light-activated molecules to selectively target cancer cells. By transforming the body’s own immune response and addressing the high costs of current cancer treatments, Invion is positioning itself as a transformative player in the biotech sector. With clinical trials underway and strong institutional partnerships, the company is bridging the gap between scientific breakthrough and accessible, scalable patient care.
From Outback to Boardroom: How SWAN Systems is Codifying Water Stewardship
From the arid deserts of Australia to the boardrooms of global tech giants, SWAN Systems is redefining water efficiency. By bridging the gap between field-level agronomics and autonomous irrigation control, the company is proving that “water-positive” targets can be met with science, data, and a 10x ROI commitment.
Backed By Leading Investment Groups and Family Offices
